Mengmeng Wu
- Topics
- SARS-CoV-2 and COVID-19 Research (8 papers)COVID-19 Clinical Research Studies (7 papers)Pancreatic and Hepatic Oncology Research (4 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsFrontiers in ImmunologyFrontiers in Microbiology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Mengmeng Wu
46 papers receiving 434 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 162
- Cancer Research 103
- Pulmonary and Respiratory Medicine 102
- Infectious Diseases 84
- Oncology 67
Countries citing papers authored by Mengmeng Wu
This map shows the geographic impact of Mengmeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Wu more than expected).
Fields of papers citing papers by Mengmeng Wu
This network shows the impact of papers produced by Mengmeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Wu. The network helps show where Mengmeng Wu may publish in the future.
Co-authorship network of co-authors of Mengmeng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Wu. A scholar is included among the top collaborators of Mengmeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Wu. Mengmeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 16 | |
| 11 | 33 | |
| 12 | 10 | |
| 13 | 22 | |
| 14 | 24 | |
| 15 | 12 | |
| 16 | 13 | |
| 17 | 13 | |
| 18 | 33 | |
| 19 | 30 | |
| 20 | 19 |
About Mengmeng Wu
Mengmeng Wu is a scholar working on Infectious Diseases, Cancer Research and Hepatology, having authored 50 papers that have together received 440 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (103 citations), Infectious Diseases (84 citations) and Obstetrics and Gynecology (25 citations). Mengmeng Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dongqin Yang, Xiaohong Wu, Songjie Wu, Ke Liang, Weiming Tang, Fuchen Liu, Wei Guo, Junjie Guo, Zhezhi Deng and Xiaobo Feng. Their work appears in journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.